{"id":45871,"date":"2026-07-27T19:56:00","date_gmt":"2026-07-27T17:56:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=04197b8112249c2051490433545c70e3"},"modified":"2026-07-27T19:56:00","modified_gmt":"2026-07-27T17:56:00","slug":"neuvotion-announces-commercialization-of-brain-computer-interface-and-brain-body-interface-technologies-related-clinical-study-published-in-nature-medicine","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=45871","title":{"rendered":"Neuvotion Announces Commercialization of Brain-Computer Interface and Brain-Body Interface Technologies \u2013 Related Clinical Study Published in Nature Medicine"},"content":{"rendered":"

\nNeuvotion is advancing AI-guided neuromodulation and brain\u2013computer interface (BCI) technologies based on its founder\u2019s groundbreaking research to create brain\u2013body interfaces that restore movement, sensation, and independence for patients facing neurological injury and disease.<\/p><\/a><\/a><\/a><\/a>

STAMFORD, Conn.--(BUSINESS WIRE)--Neuvotion, Inc.<\/a> is an early-stage medical device company developing an AI-guided neuromodulation platform to accelerate recovery after neurological events such as stroke and spinal cord injury. Its Brain-Body Interface (BBI) portfolio integrates wearable high-resolution muscle stimulation, spinal neuromodulation, and minimally invasive brain-computer interface (BCI) technologies to restore movement and sensation. By combining AI, intention-driven neurostimulation, and BCI technology, Neuvotion is translating newly published, peer-reviewed findings in Nature Medicine<\/i> into commercially available solutions designed to help millions of people living with movement and sensory impairments regain function, independence, and quality of life.<\/p>

\nA landmark study, published recently in Nature Medicine,<\/i> was led by Chad Bouton<\/a>, PhD, Neuvotion founder and CEO, during his tenure at the Feinstein Institutes for Medical Research. This and previous studies led by Dr. Bouton over a 22-year period are the scientific foundation of Neuvotion\u2019s platform. The most recent study confirms that a \u201cdouble neural bypass\u201d system can help restore targeted areas of movement and sensation simultaneously in a person with complete paralysis with lasting improvements.<\/p>

\nWhat Makes This Different<\/b><\/p>

\n\u201cThis study is the culmination of many years of work,\u201d said Dr. Bouton. \u201cThis is the first BCI to support recovery of both movement and sensation, while promoting long term gains. We are not just bypassing the injury, we are \u2018rewiring\u2019 the nervous system to promote neuroplasticity and help users worldwide regain sensation, get stronger, and regain independence \u2013 even after the system is turned off.\u201d Most brain-computer interfaces available today restore a single function \u2014 movement or communication \u2014 and rarely a sense of touch, and lasting benefits.<\/p>

\nValidated in a Landmark Study<\/b><\/p>

\nOver a three-year period of clinical testing, participant Keith Thomas, of Massapequa, NY, regained the ability to feed himself, drink from a cup, and scratch his nose and wipe his face using his own hand \u2014 producing gains in arm strength of 86% on his right side and 62% on his left, gains that persisted for months after stimulation ended.<\/p>

\nUsing a novel technique the research team calls \u201ccortical mirroring,\u201d Keith also regained the ability to feel touch in his wrist, an area that had been completely without sensation since his injury. The double neural bypass technology was precise enough to allow Keith to pick up and hold empty eggshells without breaking them, 87% of the time.<\/p>

\nThe system pairs brain implants that decode movement intent with AI-guided electrical stimulation of the spinal cord, skin, and brain \u2014 reading neural signals with over 84.6% accuracy sustained for five months without retraining.<\/p>

\n\u201cThis study marks a defining milestone,\u201d said Dr. Bouton. \u201cFor decades, we\u2019ve been pushing the boundaries of what\u2019s possible. Our goal is to translate this breakthrough from research to real-world clinical care, helping people regain movement, sensation, and ultimately, independence.\u201d<\/p>

\nNeuvotion\u2019s Commercial Path<\/b><\/p>

\nNeuvotion is bringing this foundational science to market, beginning with its NeuStim\u2122<\/a> technology, the first Food and Drug Administration (FDA)-cleared product in its brain-body interface portfolio. NeuStim\u2122 will launch this fall, providing AI-guided high resolution electrical stimulation non-invasively to muscles for promoting recovery after stroke and spinal cord injury. NeuStim\u2122 allows clinicians to setup quickly and pinpoint stimulation targets within a few minutes through an innovative touch-screen interface that allows the user to move the stimulation point electronically, eliminating the need for manual electrode removal and replacement. Furthermore, the AI-guidance capability can infer user\u2019s intentions and intuitively provides stimulation to assist with user movements, all without requiring brain surgery.<\/p>

\nThe double neural bypass technology from Dr. Bouton\u2019s lab was named to TIME\u2019s Best Inventions of the Quarter Century Hall of Fame in 2025 and TIME\u2019s Best Inventions list of 2024.<\/p>

\nNeuvotion is working with leading rehabilitation centers to expand clinical adoption of its revolutionary products, bringing advanced neurorecovery from specialized research environments into everyday clinical care.<\/p>

\nAbout Neuvotion, Inc.<\/b><\/p>

\nNeuvotion is an early-stage medical device company developing technologies that combine brain-computer interface, high-precision neurostimulation and artificial intelligence to restore movement and sensation for the millions of people affected by stroke, spinal cord injury and other neurological conditions. Founded by Dr. Chad Bouton, Neuvotion is translating peer-reviewed, clinically validated research into commercial products for the neuromodulation and neurorecovery markets.<\/p> Contacts<\/b>

\nMedia Contact:<\/b>Ally Williams\nally@mediasourcetv.com<\/a>info@neuvotion-inc.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Neuvotion is advancing AI-guided neuromodulation and brain\u2013computer interface (BCI) technologies based on its founder\u2019s groundbreaking research to create brain\u2013body interfaces that restore movement, sensation, and independence for patients facing neur…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-45871","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/45871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45871"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/45871\/revisions"}],"predecessor-version":[{"id":45872,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/45871\/revisions\/45872"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}